| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3158329 | Journal of Oral and Maxillofacial Surgery | 2010 | 6 Pages |
Abstract
Despite aggressive therapy, patients with SCC of the oral tongue have a low rate of local tumor control and survival, particularly among those with stage I-II disease. These patients should be considered for inclusion in clinical trials evaluating novel postoperative therapies.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Kyle E. MD, David MD, John I. MD, Madeleine MD, PhD, Taghrid A. BS, Changhu MD,